Bipoláris zavar: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• GLP-1 0
• BDNF 0
• NMDA 1
• SGLT2 1
• PI3K 0
• AQP4 0
• PCSK9 0
• PPAR 0
• TNF 0
• AKT 0
• BRD4 0
• G6PD 0
• IGF1R 0
• IL-1 0
• IL-17 0
• IL-6 0
• MAPT 0
• NLRP3 0
• NRF2 0
• SIRT1 0
• TFEB 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIA · R01

  Proof of Concept (Phase 0) Study of Clinical Trial Outcomes and Biomarkers in Early Stage Dementia with Lewy Bodies

  University of Miami School of Medicine· Coral Gables, Egyesült Államok· 644 011 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NIAAA · R01

  N-acetylcysteine for restoring glutamate/glutathione homeostasis and reducing heavy drinking in co-occurring bipolar and alcohol use disorders

  Medical University of South Carolina· Charleston, Egyesült Államok· 674 482 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NIMH · R56

  Certified Older Adult Peer Support Specialists Telephonic Intervention to Support Independent Living Skills in Older Adults with Serious Mental Illness

  Dartmouth-Hitchcock Clinic· Lebanon, Egyesült Államok· 1 133 543 USD awarded in fiscal year 2026· until 2027. szept.

• NIH NCCIH · R01

  CRCNS: Dynamics of inter-area interactions during sleep and psychedelic states

  Princeton University· Princeton, Egyesült Államok· 410 000 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NIMH · K23

  Integrating patient navigation with psychiatric care to increase use of HIV pre-exposure prophylaxis (PrEP) among young adults with severe mental illness

  Albert Einstein College of Medicine· Bronx, Egyesült Államok· 199 584 USD awarded in fiscal year 2026· until 2031. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  The cerebellum: a transdiagnostic personalised target for neuromodulation in psychiatry (CLOVIS)

  Universite Paris Xii Val de Marne· Creteil, Franciaország· EU contribution 1 499 500 EUR· until 2031. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-EIC-ACC

  Callyope Copilot: Speech Foundation Model for Transdiagnostic Mental Health Assessment & Relapse Mitigation (CALLYOPECOPILOT)

  Callyope· Neuilly sur Seine, Franciaország· EU contribution 2 498 053 EUR· until 2028. máj.

• European Commission (Horizon Europe) · HORIZON-ERC

  Personalized Genetic Risk Profile: A New Tool to Guide Prevention of Serious Mental Illness (PersonalRiskProfile)

  Stichting Amsterdam Umc· Amsterdam, Hollandia· EU contribution 1 499 891 EUR· until 2030. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Synaptic signatures: Understanding thalamocortical circuit specification and disease vulnerability (ThalamoLinkIT)

  Vib Vzw· Zwijnaarde - Gent, Belgium· EU contribution 200 400 EUR· until 2027. márc.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Synapsing Mental Disorders and Neurodegenerative diseases: Towards more effective diagnosis and management of psychiatric symptoms (SYNAPSING)

  Institut de Recerca de L'hospital de la Santa Creu I Sant Pau Fundacion· Barcelona, Spanyolország· EU contribution 6 999 922 EUR· until 2029. dec.· 9 countries

10 of 287 running projects, newest first. Listed amounts together: 169,1 M USD + 29,5 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 6
• Mendelian Randomization Analysis 52
• CRISPR-Cas Systems 2
• Gene Expression Profiling 23
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Exome Sequencing 3
• Proteomics 17
• Metabolomics 8
• Mass Spectrometry 3
• Immunohistochemistry 1
• Positron-Emission Tomography 13
• Magnetic Resonance Imaging 190
• Machine Learning 59
• Deep Learning 9
• Cohort Studies 96
• Genome-Wide Association Study 107

• Investigating Causal Relationships Between Major Mental Disorders and Hypertension Subtypes and Their Complications: A Mendelian Randomization Study.

  Genes Brain Behav, 2026. dec.

• Psychiatric disorders and gynecologic tumors: A 2-sample Mendelian randomization study of 20 exposure-outcome pairs.

  Medicine (Baltimore), 2026. szept.

• Mapping the Immune cell-specific gene regulatory network in bipolar disorder: A framework from scTWMR to exploratory drug-target annotation.

  Psychiatry Res, 2026. szept.

• Causal association between cataract and psychiatric disorders: A bidirectional 2-sample Mendelian randomization study.

  Medicine (Baltimore), 2026. aug.

• Does Toxoplasma gondii infection have a causal impact on human psychopathology? A Mendelian randomization analysis.

  PLoS Pathog, 2026. aug.

• Unravelling the role of alanine in mental disorders: a Mendelian randomisation study.

  J Nutr Sci, 2026. júl.

• Glucagon-like peptide-1 receptor activation and mental health: a drug-target mendelian randomization study.

  Transl Psychiatry, 2026. júl.

• Relationship between mental disorders and non-traumatic cerebral hemorrhage: cross-sectional analysis and mendelian randomization.

  PeerJ, 2026. jún.

• Unraveling the bidirectional association between mental disorders and prostatitis: insights from a genetic perspective.

  Can J Urol, 2026. jún.

• Cytomegalovirus-related immune activation and major neuropsychiatric disorders: Mendelian randomization and bulk transcriptomic validation.

  Psychiatry Res, 2026. jún.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.